Aisling Capital

Website Links

Description

Newly Formed Durata Therapeutics Acquires Pfizer’s Vicuron Subsidiary December 21, 2009 Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications December 18, 2009 LensAR Incorporated to Present Data from Laser Cataract Surgery Clinical Trial at the Annual Meeting of the American Academy of Ophthalmology October 13, 2009 TransEnterix Secures $55 Million in Financing October 7, 2009 Novartis gains exclusive worldwide rights to PTK 0796, in Phase III study as potential first-in-class IV and oral broad-spectrum antibiotic October 08, 2009 Allos Therapeutics' FOLOTYN™ First and Only FDA-Approved Therapy for Relapsed or Refractory Peripheral T-cell Lymphoma September 25, 2009 Sirion Therapeutics Announces FDA Approval of Zirgan™ (ganciclovir ophthalmic gel) 0.15% for Herpetic Keratitis September 16, 2009 VIVUS Announces Positive Results From Two Phase 3 Studies; Obese Patients on Qnexa Achieve Average Weight Loss up to 14.7% and Significant Improvements in Co-Morbidities September 9, 2009 Xanodyne Receives Approval From the U.S. Food and Drug Administration for ZIPSOR™ (diclofenac potassium) Liquid Filled Capsules June 17, 2009 MAP Pharmaceuticals Phase 3 Trial of LEVADEX™ Migraine Product Candidate Meets All Four Primary Endpoints May 26, 2009 SkinMedica to Co-promote ACZONE

Products & services

Similar companies nearby